Article
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses the latest advancements in OIC treatment.
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses the latest advancements in OIC treatment.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval